Dr Reddy’s Laboratories announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo (Naproxen and Esomeprazole Magnesium) delayed-release tablets approved by the US Food and Drug Administration (USFDA).
“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, chief executive officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo tablets and to offer an affordable treatment alternative for patients.”
The Vimovo (Naproxen and Esomeprazole Magnesium) delayed-release tablets brand had US sales of approximately US $ 414 million (approximately Rs 3000 crore) MAT for the most recent twelve months ending in December 2019 according to IQVIA Health.
Dr Reddy’s Naproxen and Esomeprazole Magnesium delayed-release tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of 60.
